NCT05896696 - Efficacy and Safety of the BeShape One Device for Non-invasive Waist Circumference Reduction | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 28, 2022

Primary Completion Date

March 16, 2023

Study Completion Date

April 27, 2023

Conditions

Dermatological Non-Disease

Interventions

DEVICE

BeShape One

Single treatment with the BeShape One device. Participants will receive treatment on at least 4 abdomen/flanks treatment areas and up to 6 treatment areas, at the discretion of the investigator. The subject will receive one treatment on each treatment area.

Trial Locations (2)

60654

Chicago Cosmetic Surgery and Dermatology, Chicago

Unknown

Centro Poliklinika, Vilnius